{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:08:13Z","timestamp":1787242093423,"version":"build-2736575974"},"reference-count":37,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2025,4,30]]},"DOI":"10.5582\/ddt.2025.01011","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T18:07:38Z","timestamp":1746727658000},"page":"112-123","source":"Crossref","is-referenced-by-count":1,"title":["Clinical benefits of rapid initiation of antiretroviral therapy within 14 days for newly diagnosed late-presentation people living with human immunodeficiency virus (PLWH)"],"prefix":"10.5582","volume":"19","author":[{"given":"Xiang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjing","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Di","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rentian","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, Jiangsu, China."},{"name":"Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","unstructured":"1. World Health Organization. HIV\/AIDS. Available at <i>https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids.<\/i> 2022."},{"key":"2","unstructured":"2. Han M. Analysis of the HIV\/AIDS Epidemic Situation in China and Prospects for Prevention and Control. Zhongguo Ai Zi Bing Xing Bing. 2023; 29:247-250 (in Chinese)."},{"key":"3","unstructured":"3. WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy. World Health Organization. 2017."},{"key":"4","unstructured":"4. UNAIDS_Global HIV &amp; AIDS Statistics-2019 Fact Sheet: Latest Statistics on the Status of the AIDS Epidemic, World Aids Day. <i>https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf.<\/i> 2020."},{"key":"5","unstructured":"5. WHO Guidelines Approved by the Guidelines Review Committee, Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva, 2015."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yang X, Li X, Qiao S, Zhang Q, Shen Z, Zhou Y. Immunological and virologic outcomes of people living with HIV in Guangxi, China: 2012-2017. PLoS One. 2019; 14:e0213205.","DOI":"10.1371\/journal.pone.0213205"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zhang F-G, Ma Y. Progress and challenges in China&apos;s free ART programme. Lancet HIV. 2019; 6:e8-e9.","DOI":"10.1016\/S2352-3018(18)30364-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ford N, Migone C, Calmy A, Kerschberger B, Kanters S, Nsanzimana S, Mills EJ, Meintjes G, Vitoria M, Doherty M, Shubber Z. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS. 2018; 32:17-23.","DOI":"10.1097\/QAD.0000000000001671"},{"key":"9","unstructured":"9. Jiao J, Dai L, Chen X. Research progress on rapid antiviral treatment strategies for HIV\/AIDS. Zhongguo Ai Zi Bing Xing Bing. 2020; 26:660-663."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Zhao Y, Wu Z, McGoogan JM, Shi CX, Li A, Dou Z, Ma Y, Qin Q, Brookmeyer R, Detels R, Montaner JSG. Immediate antiretroviral therapy decreases mortality among patients with high CD4 counts in China: A nationwide, retrospective cohort study. Clin Infect Dis. 2018; 66:727-734.","DOI":"10.1093\/cid\/cix878"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Girometti N, Nwokolo N, McOwan A, Whitlock G. Outcomes of acutely HIV-1-infected individuals following rapid antiretroviral therapy initiation. Antivir Ther. 2017; 22:77-80.","DOI":"10.3851\/IMP3080"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hoenigl M, Chaillon A, Moore DJ, Morris SR, Mehta SR, Gianella S, Amico KR, Little SJ. Rapid HIV viral load suppression in those initiating antiretroviral therapy at first visit after HIV diagnosis. Sci Rep. 2016; 6:32947.","DOI":"10.1038\/srep32947"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Koenig SP, Dorvil N, D\u00e9vieux JG<i>, et al.<\/i> Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial. PLoS Med. 2017; 14:e1002357.","DOI":"10.1371\/journal.pmed.1002357"},{"key":"14","unstructured":"14. Bacon O, Chin J, L. H. The Rapid ART Program Initiative for HIV Diagnoses (RAPID) in San Francisco. In: Conference on Retroviruses and Opportunistic Infections; 2018 Mar 4-7; Boston, MA."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dijkstra M, van Rooijen MS, Hillebregt MM, <i>et al.<\/i> Decreased time to viral suppression after implementation of targeted testing and immediate initiation of treatment of acute human immunodeficiency virus infection among men who have sex with men in Amsterdam. Clin Infect Dis. 2021; 72:1952-1960.","DOI":"10.1093\/cid\/ciaa505"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Halperin J, Butler I, Conner K, Myers L, Holm P, Bartram L, Van Sickels N. Linkage and antiretroviral therapy within 72 hours at a federally qualified health center in New Orleans. AIDS Patient Care STDS. 2018; 32:39-41.","DOI":"10.1089\/apc.2017.0309"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Labhardt ND, Ringera I, Lejone TI, Klimkait T, Muhairwe J, Amstutz A, Glass TR. Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: The CASCADE randomized clinical trial. JAMA. 2018; 319:1103-1112.","DOI":"10.1001\/jama.2018.1818"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, Calderon F, Demicco E, Geng E, Gandhi M, Havlir DV, Hatano H. The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting. J Acquir Immune Defic Syndr. 2017; 74:44-51.","DOI":"10.1097\/QAI.0000000000001134"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wu Z, Zhao Y, Ge X<i>, et al.<\/i> Simplified HIV testing and treatment in China: Analysis of mortality rates before and after a structural intervention. PLoS Med. 2015; 12:e1001874.","DOI":"10.1371\/journal.pmed.1001874"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Colasanti J, Sumitani J, Mehta CC, Zhang Y, Nguyen ML, Del Rio C, Armstrong WS. Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the Southern United States. Open Forum Infect Dis. 2018; 5:ofy104.","DOI":"10.1093\/ofid\/ofy104"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sun J, Liu L, Shen J, Chen P, Lu H. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study. BMC Infect Dis. 2017; 17:285.","DOI":"10.1186\/s12879-017-2398-5"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lin KY, Cheng CY, Li CW, <i>et al.<\/i> Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up. PloS One. 2017; 12:e0179870.","DOI":"10.1371\/journal.pone.0179870"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Antinori A, Coenen T, Costagiola D, <i>et al.<\/i> Late presentation of HIV infection: a consensus definition. HIV Med. 2011; 12:61-64.","DOI":"10.1111\/j.1468-1293.2010.00857.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, Bernal E, Asensi V, Pulido F, del Amo J, Hernando V. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013. J Infect. 2016; 72:587-596.","DOI":"10.1016\/j.jinf.2016.01.017"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, Phillips AN, Prinz B, Youle M, Johnson MA. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004; 18:2145-2151.","DOI":"10.1097\/00002030-200411050-00006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, Crane HM, Willig J, Mugavero M, Saag M, Martin JN, Deeks SG. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009; 48:787-794.","DOI":"10.1086\/597093"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Jevtovi\u0107 D, Vanovac V, Veselinovi\u0107 M, Salemovi\u0107 D, Ranin J, Stefanova E. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART. Biomed Pharmacother. 2009; 63:561-565.","DOI":"10.1016\/j.biopha.2008.09.015"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006; 20:1447-1450.","DOI":"10.1097\/01.aids.0000233579.79714.8d"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. van Opstal SEM, van der Zwan JS, Wagener MN, Been SK, Miedema HS, Roelofs P, van Gorp ECM. Late presentation of HIV infection in the Netherlands: Reasons for late diagnoses and impact on vocational functioning. AIDS Behav. 2018; 22:2593-2603.","DOI":"10.1007\/s10461-018-2082-9"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Huang YC, Sun HY, Chuang YC, Huang YS, Lin KY, Huang SH, Chen GJ, Luo YZ, Wu PY, Liu WC, Hung CC, Chang SC. Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: real-world experience from a single-centre retrospective cohort in Taiwan. BMJ Open. 2019; 9:e033246.","DOI":"10.1136\/bmjopen-2019-033246"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Labhardt ND, Ringera I, Lejone TI, Klimkait T, Muhairwe J, Amstutz A, Glass TR. Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: The CASCADE randomized clinical trial. JAMA. 2018; 319:1103-1112.","DOI":"10.1001\/jama.2018.1818"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lee CY, Lee CH, Tang HJ, Tsai HC, Yang CH, Lin YP, Wang SF, Lu PL. Comparison of Virological Efficacy of DTG\/ABC\/3TG and B\/F\/TAF Regimens and Discontinuation Patterns in Persons Living with Advanced HIV in the Era of Rapid ART: A Retrospective Multicenter Cohort Study. Infect Dis Ther. 2023; 12:843-861.","DOI":"10.1007\/s40121-022-00734-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Camici M, Gagliardini R, Lanini S, <i>et al.<\/i> Rapid ART initiation with bictegravir\/emtricitabine\/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study). Int J Antimicrob Agents. 2024; 63:107049.","DOI":"10.1016\/j.ijantimicag.2023.107049"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, Sanne I, Bokaba D, Sauls C, Rohr J, Long L. Initiating antiretroviral therapy for HIV at a patient&apos;s first clinic visit: The RapIT randomized controlled trial. PLoS Med. 2016; 13:e1002015.","DOI":"10.1371\/journal.pmed.1002015"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Seekaew P, Phanuphak N, Teeratakulpisarn N, Amatavete S, Lujintanon S, Teeratakulpisarn S, Pankam T, Nampaisan O, Jomja P, Prabjunteuk C, Plodgratoke P, Ramautarsing R, Phanuphak P. Same-day antiretroviral therapy initiation hub model at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: An observational cohort study. J Int AIDS Soc. 2021; 24:e25869.","DOI":"10.1002\/jia2.25869"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Halperin J, Conner K, Butler I, Zeng P, Myers L, Clark R, Van Sickels N. A care continuum of immediate ART for newly diagnosed patients and patients presenting later to care at a federally qualified health center in New Orleans. Open Forum Infect Dis. 2019; 6:ofz161.","DOI":"10.1093\/ofid\/ofz161"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Zhabokritsky A, Szadkowski L, Cooper C, Loutfy M, Wong A, McClean A, Hogg RS, Walmsley SL. Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelines. J Antimicrob Chemother. 2021; 76:729-737.","DOI":"10.1093\/jac\/dkaa484"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/2\/19_2025.01011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:20:28Z","timestamp":1746836428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/2\/19_2025.01011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2025.01011","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"article-number":"2025.01011"}}